High Indoleamine 2,3-Dioxygenase Expression along with Low Bridging Integrator-1 Expression in Hepatocellular Carcinoma Patients

BACKGROUND: Hepatocellular carcinoma (HCC) adopts several tumor immune escape mechanisms; therefore, it has the potential to be targeted by immunotherapy. Indoleamine 2, 3-dioxygenase (IDO) is an immunosuppressive enzyme that has been observed to be overexpressed in HCC patients with poor prognoses....

Descripción completa

Detalles Bibliográficos
Autores principales: Asghar, Kashif, Rana, Iftikhar Ali, Abu Bakar, Muhammad, Hasham, Kinza, Tahseen, Muhammad, Bilal, Sundus, Mehmood, Shafqat, Farooq, Asim, Siddique, Kashif, Loya, Asif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495885/
https://www.ncbi.nlm.nih.gov/pubmed/37247278
http://dx.doi.org/10.31557/APJCP.2023.24.5.1591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495885/
https://www.ncbi.nlm.nih.gov/pubmed/37247278
http://dx.doi.org/10.31557/APJCP.2023.24.5.1591

Ejemplares similares